Lgt Financial Advisors LLC Sarepta Therapeutics, Inc. Transaction History
Lgt Financial Advisors LLC
- $40.5 Billion
- Q3 2024
A detailed history of Lgt Financial Advisors LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Lgt Financial Advisors LLC holds 92 shares of SRPT stock, worth $9,629. This represents 0.03% of its overall portfolio holdings.
Number of Shares
92
Previous 93
1.08%
Holding current value
$9,629
Previous $14.7 Million
21.8%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding SRPT
# of Institutions
531Shares Held
84.5MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.08 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$939 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$655 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$456 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$447 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.17B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...